This contract expires in 415 days (Sep 12, 2027).
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. - CTPE ANTHRAX AV7909 BOOST EVALUATION AND ANTIGEN-SPARING TRIAL (ABEAST)
Key Details
Description
CTPE ANTHRAX AV7909 BOOST EVALUATION AND ANTIGEN-SPARING TRIAL (ABEAST)
Context & Analysis
On Dec 8, 2025, Department of Health and Human Services obligated $10,320,205 to ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. for ctpe anthrax av7909 boost evaluation and antigen-sparing trial (abeast). The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in HINCKLEY, OH. The contract is scheduled through Sep 12, 2027 — approximately 14 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.